In the Q2, Evolent Health Inc 's corporate clients experienced a reduction by -7.64 % in their costs of revenue, compared to a year ago, sequentially costs of revenue were trimmed by -2.57 %. During the corresponding time, Evolent Health Inc recorded a revenue increase by 46.86 % year on year, sequentially revenue grew by 31.49 %. While revenue at the Evolent Health Inc 's corporate clients recorded rose by 3.18 % year on year, sequentially revenue grew by 2.05 %.
Customers of Evolent Health Inc saw their costs of revenue decrease by -7.64 % in Q2 compare to a year ago, sequentially costs of revenue were trimmed by -2.57 %, for the same period Evolent Health Inc recorded revenue increase by 46.86 % year on year, sequentially revenue grew by 31.49 %.
Evolent Health Inc's Comment on Sales, Marketing and Customers
Evolent provides Specialty Care Management Services to physicians and healthcare providers, focusing on evidence-based clinical pathways to enhance patient outcomes, improve physician experience, and reduce healthcare costs. Its clients include health plans and other risk-bearing entities managing specialty care in oncology, cardiology, musculoskeletal, radiology, physical medicine, and genetics. Evolent serves Medicare members through performance-based and technology arrangements, concentrating on oncology, cardiology, and musculoskeletal markets supported by diagnostics such as radiology and genetics. Founded in 2011 with involvement from UPMC and The Advisory Board Company, Evolent has expanded through acquisitions, including New Century Health, a national leader in managing specialty care for Medicare members.
Evolent Health Inc’s Comment on Sales, Marketing and Customers
Evolent provides Specialty Care Management Services to physicians and healthcare providers, focusing on evidence-based clinical pathways to enhance patient outcomes, improve physician experience, and reduce healthcare costs. Its clients include health plans and other risk-bearing entities managing specialty care in oncology, cardiology, musculoskeletal, radiology, physical medicine, and genetics. Evolent serves Medicare members through performance-based and technology arrangements, concentrating on oncology, cardiology, and musculoskeletal markets supported by diagnostics such as radiology and genetics. Founded in 2011 with involvement from UPMC and The Advisory Board Company, Evolent has expanded through acquisitions, including New Century Health, a national leader in managing specialty care for Medicare members.
Sources:
Evolent Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Evolent Health Inc’s corporate clients.
For your research, we’ve provided 9 tables on Evolent Health Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
176.05 %
3.18 %